SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-010553
Filing Date
2023-04-18
Accepted
2023-04-18 16:10:08
Documents
16
Period of Report
2023-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20230417_8k.htm   iXBRL 8-K 48378
2 EXHIBIT 3.1 ex_501510.htm EX-3.1 93617
3 EXHIBIT 3.2 ex_501511.htm EX-3.2 22624
4 EXHIBIT 10.1 ex_501512.htm EX-10.1 47879
  Complete submission text file 0001437749-23-010553.txt   392035

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbla-20230414.xsd EX-101.SCH 3601
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20230414_def.xml EX-101.DEF 11916
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20230414_lab.xml EX-101.LAB 15956
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20230414_pre.xml EX-101.PRE 12127
10 EXTRACTED XBRL INSTANCE DOCUMENT pbla20230417_8k_htm.xml XML 2661
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 23826947
SIC: 2834 Pharmaceutical Preparations